MAPK8 and neoplasm: A loss-of-function mutation in the cJUN NH2-terminal kinase (JNK) signaling pathway switches on the AP1 transcription factor and downregulates JNK signaling, promoting genomic instability and tumor development (Girnius et al. 2018).